X-ray crystallography remains the primary technique for determining protein and macromolecular complex structures at atomic resolution. By diffracting X-rays through protein crystals and analyzing the resulting diffraction patterns, electron density maps are computed from which complete atomic models are built and refined to Ångström-level precision.
iCDMO's crystallography service covers the complete pipeline — from gene-to-crystal protein production, high-throughput crystallization screening with 2,000+ conditions, and synchrotron data collection at Diamond, ESRF, APS, SSRF, and Spring 8, through structure determination, PDB deposition, and biological interpretation — all under one roof.
Our systematic three-phase approach — from initial high-throughput screening to crystal identification — maximizes success even for challenging targets.
Vapor diffusion is the core technique in our crystallization platform, implemented via sitting-drop and hanging-drop methods.
A systematic, quality-controlled pipeline that has delivered 300+ high-resolution structures across all target classes.
The complete X-ray crystallography pipeline — from growing the crystal to depositing refined atomic coordinates in the PDB.
X-ray crystallography routinely achieves 1.0–2.5 Å resolution — sufficient to resolve individual atoms, water molecules, and bound ligand geometry with full precision.
Industry-standard for structure-based drug design: visualize how inhibitors, fragments, and drug candidates bind within the active site at atomic detail.
Established access to major global beamlines (Diamond, ESRF, APS, SSRF, Spring 8) ensures highest-quality diffraction data for even weakly diffracting crystals.
Our structure gallery of 300+ solved proteins provides search models for rapid Molecular Replacement phasing, cutting time-to-structure for related targets.
All structures validated to PDB wwPDB criteria — Rfree, Ramachandran, MolProbity scores — and deposited with full structure factor files for open access.
Fragment soaking campaigns against pre-formed crystals: screen 500–1,000 fragments crystallographically to identify novel chemical starting points for lead discovery.
Note: Timelines are estimates for well-behaved samples. Challenging targets or low-symmetry crystal forms may require additional optimization cycles. Contact us for a free feasibility assessment before project initiation.
Share your target details and our crystallographers will assess feasibility and recommend the optimal crystallization strategy within 24 hours.
Contact Us Online Consultation